Pinsent Masons celebrates innovation in the Biotech Sector at Bionow Awards

10 Dec 2013 | 01:30 pm | 1 min. read

International law firm Pinsent Masons has presented UK company Cyprotex with the 'Service Company of the Year' award at the Bionow Annual Awards 2013.

The awards, which took place on Thursday 28th November at The Mere Golf Resort & Spa in Cheshire, celebrates business and innovation within the biomedical and life science sectors across Northern England and showcases the world class offerings in the region.  It is was attended by over 300 executives from across the biomedical industry.

Samantha Livesey, Partner at Pinsent Masons specialising in intellectual property and commercial contracts within the biotech sector, was delighted to present the Service Company of the Year Award to Cyptrotex, whose ADME-Tox contract research services scored strongly against the judging criteria of impact of service on the problem addressed, quality and innovation of service and strong business model. 

Anthony Baxter PhD, chief executive of Cyprotex, said: "We are delighted to have won the prestigious BioNow Service Company of the Year award. Our dedicated team at our facilities in the UK and the US has made this possible and they have worked hard to achieve where we are today...We are looking forward to further growth and expansion during 2014."

Samantha Livesey said: "The BioNow Annual Awards are a great opportunity to celebrate the continued innovation and hard work of the companies operating in the biomedical field in the North.  It was fantastic to see so many growth-orientated companies from this sector sharing their expertise and networking, whether their main operation was scientific, clinical or business related."

The Service Company of the Year was a hugely competitive category with runners up Cobra Biologics and Perfectus Biomed also both making strong submissions. 

Key Contacts

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

Pinsent Masons advises AMC Entertainment Holdings, Inc. on €65m sale of Baltic region theatre locations

Multinational law firm Pinsent Masons has advised AMC Entertainment Holdings, Inc (AMC) on the €65m ($77 million) sale of nine theatre locations across the Baltic region to Up Invest.

Pinsent Masons advises Straumann on investment in DrSmile

Pinsent Masons has advised the Straumann Group on its acquisition of a significant majority stake in DrSmile – a leading dental provider of orthodontic treatment solutions in Germany.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts